5-Iodo-2-aminoindane (5-IAI) is an entactogen drug of the 2-aminoindane group. [2] . Human anecdotal reports suggest that it is entactogenic but produces little euphoria or stimulation. [2] …

2013年3月27日 · In 2011, this compound, a psychoactive derivative of 2-aminoindane, was identified in recreational products sold in the United Kingdom. 5-IAI is a rigid analogue of p …

5-Iodo-2-aminoindan | C9H10IN | CID 131506 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity …

2010年8月13日 · 5-IAI (5-Iodo-2-aminoindane) is a rigid analogue of amphetamine that has been demonstrated to behaviorally substitute for MDMA, and acts as a monoamine releasing agent. …

5-Iodo-2-aminoindane (5-IAI) is an entactogen drug of the 2-aminoindane group. Human anecdotal reports suggest that it is entactogenic but produces little euphoria or stimulation. …

2014年3月15日 · We characterized the pharmacology of the aminoindanes 5,6-methylenedioxy-2-aminoindane (MDAI), 5-iodoaminoindane (5-IAI), and 2-aminoindane (2-AI), the piperazines …

5-IAI is a psychoactive analog of p-iodoamphetamine and is indistinguishable, in its physiological effects, from 3,4-methylenedioxymethamphetamine in rats. 1 A single 40 mg/kg dose of 5-IAI …

Aliases: 5iai. A monoamine triple releaser first synthesised by David Nichols, possesses similar properties to MDMA. Probably neurotoxic in humans, however the extent of this is unclear.

ABSTRACT: The synthesis, analysis, and characterization of 4- and 5-iodo-2-aminoindan (commonly referred to as “4-IAI” and “5-IAI”) are discussed. Analytical data (mass …

A rigid analogue, 5-iodo-2-aminoindan (5-IAI), of the serotonin neurotoxic halogenated amphetamine p-iodoamphetamine (PIA) was pharmacologically evaluated for production of …